Quantcast

Latest Akesis Pharmaceuticals Inc. Stories

2008-11-06 06:00:21

Akesis Pharmaceuticals, Inc. (OTCBB:AKES) today announced it is broadening its business model to include the development of a wider range of specialty pharmaceuticals targeting metabolic diseases.

2008-11-05 06:00:20

Akesis Pharmaceuticals, Inc. (OTCBB:AKES) today announced that current president and chief operating officer, Carl LeBel, Ph.D., has been appointed to the role of president and chief executive officer. Dr.

2008-09-22 06:00:30

Akesis Pharmaceuticals, Inc. (OTCBB:AKES), an emerging diabetes drug-development company, today announced the initiation of the next phase of the preclinical safety program for AKP-020.

2008-07-18 12:01:14

Akesis Pharmaceuticals, Inc. (OTCBB: AKES), an emerging metabolic disease drug development company, today announced it has appointed Christos Mantzoros, MD, DSc, to its scientific advisory board (SAB). Dr.

2008-06-30 09:03:37

Akesis Pharmaceuticals, Inc. (OTCBB:AKES), an emerging diabetes drug-development company, today announced it has named Carl LeBel, Ph.D., as president and chief operating officer. Dr. LeBel has served on Akesis' board of directors since December 2007.

2008-06-24 09:03:24

Akesis Pharmaceuticals, Inc. (OTCBB:AKES), an emerging diabetes drug-development company, today announced it plans to begin a 13-week preclinical safety program for AKP-020, a novel vanadium compound that has shown considerable potential as a treatment for Type 2 diabetes.


Word of the Day
edulcoration
  • The act of sweetening by admixture of some saccharine substance.
The word 'edulcoration' comes from a Latin word meaning 'making sweet'.